Filter by: Subject

Filter by: Subject

Results Per Page:

South Africa (SA) (56)
Tuberculosis (TB) (53)
Human immunodeficiency virus (HIV) (46)
Mycobacterium tuberculosis (MTB) (29)
SDG-03: Good health and well-being (24)
Sexually transmitted infection (STI) (20)
Multidrug-resistant (MDR) (19)
Drug resistance (13)
Mycobacterium tuberculosis (13)
Escherichia coli (12)
Africa (11)
Antimicrobial resistance (AMR) (11)
Bedaquiline (10)
Enterobacteriaceae (10)
Infection (10)
Multidrug-resistant tuberculosis (MDR-TB) (9)
Polymerase chain reaction (PCR) (9)
Pregnancy (9)
South Africa (9)
Antibiotic resistance (8)
Antiretroviral therapy (ART) (8)
Molecular epidemiology (8)
Patients (8)
Pregnant women (8)
Sub-Saharan Africa (SSA) (8)
Women (8)
Chlamydia trachomatis (7)
Drug-resistant tuberculosis (DR-TB) (7)
Surveillance (7)
Whole genome sequencing (WGS) (7)
Whole-genome sequencing (WGS) (7)
Acinetobacter baumannii (6)
Antimicrobial resistance (6)
Bacterial vaginosis (BV) (6)
Diagnosis (6)
Epidemiology (6)
Neisseria gonorrhoeae (6)
Treatment (6)
Acquired immune deficiency syndrome (AIDS) (5)
Bacteria (5)
Clofazimine (5)
Colistin (5)
Coronavirus disease 2019 (COVID-19) (5)
COVID-19 pandemic (5)
Drug susceptibility testing (DST) (5)
Extensively drug-resistant tuberculosis (XDR-TB) (5)
Klebsiella pneumoniae (5)
Men who have sex with men (MSM) (5)
Microbiome (5)
Public health (5)
Antibiotics (4)
Carbapenemase (4)
Diagnostics (4)
Ethiopia (4)
Genotyping (4)
Infections (4)
Microbiology (4)
Mobilome (4)
Population-based surveillance (4)
Resistome (4)
Rural South Africa (4)
Staphylococcus aureus (4)
Trichomonas vaginalis (4)
Urinary tract infection (UTI) (4)
Vaccine (4)
Adolescent girls and young women (AGYW) (3)
Anti-infective agents -- South Africa (3)
Biofilm (3)
Bovine mastitis (3)
Carbapenem resistance (3)
Carbapenemases (3)
Children (3)
Ciprofloxacin (3)
Clinical trials (3)
Clofazimine (CFZ) (3)
Colistin resistance (3)
Drug resistance in microorganisms -- South Africa (3)
Gauteng Province, South Africa (3)
Genome (3)
HIV infection (3)
Human (3)
Infants (3)
Inflammation (3)
Klebsiella pneumoniae carbapenemase (KPC) (3)
MDR-TB (3)
Meningitis (3)
Molecular detection (3)
Multi-drug resistant tuberculosis (MDR-TB) (3)
Multilocus sequence typing (MLST) (3)
Mutation (3)
Mycoplasma genitalium (3)
Newborns (3)
Nosocomial infections -- South Africa (3)
Pre-exposure prophylaxis (PrEP) (3)
Preterm birth (3)
Pseudomonas aeruginosa (3)
Pulsed-field gel electrophoresis (PFGE) (3)
Pyrazinamide resistance (3)
Reproductive tract infections (RTIs) (3)
Rifampicin-resistant tuberculosis (3)